Mnemonic for the Diagnosis of Hypomania Associated with Bipolar II Disorder
Dear Editor:
In the area of primary care psychiatry and general psychiatry, the 1990s could be termed "the decade of the antidepressants." This was a period of intense medical and public education focusing on depression as a legitimate, biologically based illness amenable to treatments with many newly available and different classes of antidepressants. This effort has helped alleviate the suffering of many patients and given clinicians-especially primary care physicians-new knowledge and tools to treat depressive illness. However, 15 years after the introduction of the first selective serotonin reuptake inhibitor (SSRI), fluoxetine, it is becoming apparent that antidepressants do not work for everyone: in controlled trials, the rate of symptom remission for antidepressant therapy is at best 50% (1,2). Of more concern is the observation that antidepressants can make some patients worse by introducing or worsening anxious, agitated, or restless states and sometimes inducing insomnia intermingled with racing thought (3, 4) . Emerging evidence suggests that these antidepressant activations may be a result of unrecognized bipolar disorder (BD), usually BD II, which is being increasingly recognized as a common mood disorder both in outpatient psychiatry (5) and in primary care (6) . Affected patients usually present in the depressed state, because their hypomanic episodes are typically elated and adaptive; patients suffering from depression lack specific recall of them (7) . Because patients lack recall of hypomanic episodes, recognizing bipolar illness has been problematic, even in psychiatric settings (8, 9) . There is an average delay of 8 to 12 years before an accurate diagnosis is made. To help identify possible hypomanic episodes in a depression patient's history, and thereby decrease the delay in accurate diagnosis, we have come up with a mnemonic incorporating the DSM-IV-R definition of hypomania. We believe that, by using this mnemonic to remind ourselves to look for the presence of hypomanic episodes in all depression patients in clinical settings, we can more accurately diagnose BD in a shorter time frame. This will allow us to use more appropriate therapies to treat BD patients and to avoid embarking on an antidepressant misadventure resulting in more suffering for our patients. In other words, when the patient is low, we should think HIGH-4! John F Chiu, MD, CCFP Pratap R Chokka, MD, FRCPC Edmonton, Alberta
Aripiprazole-Induced Improvement in Tardive Dyskinesia
Atypical antipsychotics, particularly clozapine, have been reported effective in the treatment of tardive dyskinesia (TD) (1) . We report the case of a patient with schizoaffective disorder who showed remarkable improvement in TD following treatment with aripiprazole (APZ).
Case Report
Mrs A, aged 41 years, suffered from chronic schizoaffective disorder of 20 years' duration and was admitted with psychotic exacerbation. The patient had been free of antipsychotics for the last 6 months but had significant TD in the form of choreoathetoid movement of her upper extremities and truncal dyskinesia. TD was first noticed about 2 years ago, while she was taking haloperidol. Discontinuation of haloperidol and subsequent sequential trials of risperidone, olanzapine, ziprasidone, and quetiapine did not improve the TD. Quetiapine exacerbated the TD and olanzapine, ziprasidone, and risperidone had to be discontinued owing to weight gain, EKG changes, and hyperprolactinemia, 
